RegeneRx Biopharmaceuticals, Inc.
Market price today
RegeneRx Biopharmaceuticals, Inc. (RGRX) Stock Price & Analysis
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Return on Assets
Return on Equity
Return on Capital Employed
Return on Investments
Company general description and statistics
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
Frequently Asked Question
How many company shares are outstanding in 2023?
There are stock number shares outstanding of RegeneRx Biopharmaceuticals, Inc. (RGRX) on the PNK in 2023.
What is P/E ratio of enterprise in 2023?
The current P/E ratio of enterprise is -1.925 in 2023.
What is the ticker symbol of RegeneRx Biopharmaceuticals, Inc. stock?
The ticker symbol of RegeneRx Biopharmaceuticals, Inc. stock is RGRX.
What is company IPO date?
IPO date of RegeneRx Biopharmaceuticals, Inc. is 2003-10-07.
What is company current share price?
Current share price is 0.025 USD.
What is stock market cap today?
The market cap of stock today is 3712485.000.
What is PEG ratio in 2023?
The current -0.050 is -0.050 in 2023.
What is the number of employees in 2023?
In 2023 the company has 2.